A Study Comparing ETHICON™ 4000 Stapler System With Standard of Care Stapling Devices in Adults Undergoing Gastric and Thoracic Procedures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEthicon Endo-Surgery

About this trial

The purpose of this study is to compare how well the ETHICON™ 4000 Stapler works as compared to the standard stapling devices by assessing how often air leaks and bleeding along the staple line occur during lung and stomach surgeries and by evaluating the side effects occurring within 30 days of surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Prior to study enrollment, the participant and treating surgeon must have determined to proceed with one of the following surgical procedures as part of routine clinical care: a. A gastric procedure (sleeve gastrectomy) involving stapling of the stomach; or b. A thoracic procedure (lung resection limited to lobectomy, segmentectomy, or wedge resection) involving stapling of the lung

Willingness to give consent and comply with all study-related evaluations and visit schedule

At least 18 years of age

Disqualifiers

Physical or psychological condition which would impair study participation

The planned procedure is a revision/ reoperation for the same indication or same anatomical location

Trauma participants

Any condition or clinically significant finding that, in the Investigator's judgement, may interfere with study participation, impact the assessment of endpoints, or compromise the patient's safety or welfare

Trial design

Design model

Parallel

Treatments tested in this trial

  • ETHICON™ 4000 Stapler System

    Device

    The Investigator will use the ETHICON™ 4000 Stapler System, as per instructions for use (IFU). This system is composed of two primary components: The ETHICON 4000 Stapler and the ETHICON 3D Reloads.

  • Standard of Care Stapler and Reloads

    Device

    The Investigator will choose a commercially available stapler and reload(s) per their professional preference produced by any manufacturer and aligned with the manufacturer's IFU. The only exception is that the Investigator may not use the ETHICON™ 4000 Stapler System.

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: Standard of Care Stapler SystemActive comparator 1 intervention
Group B: ETHICON 4000 Stapler SystemExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Gastrointestinal- Percentage of Firings Associated with Each Intraoperative Grade of Bleeding at the Staple Line

Percentage of firings associated with each intraoperative grade of bleeding at the staple line (prior to prophylactic or intervention to the staple line) will be reported. The percentage of staple firings for each bleeding grade and for bleeding scores of 4 or below, 3 or below, 2 or below, 1 or below, and 0 will be estimated.

Time frame
Intraoperative
2

Thoracic- Percentage of Firings Associated with Intraoperative Air Leak at the Staple Line

Percentage of firings associated with intraoperative air leak at the staple line (prior to prophylactic or intervention to the staple line) will be reported.

Time frame
Intraoperative

Secondary outcomes

1

Length of Hospital Stay

Number of days from the date of hospital admission to discharge from the hospital will be reported.

Time frame
Up to 30 Days Post Procedure
2

Gastrointestinal: Percentage of Participants Experiencing Gastric Leak Up to 30 Days Post-Procedure

Percentage of participants experiencing gastric leak occurring up to 30 days post procedure will be reported.

Time frame
Up to 30 Days Post Procedure
3

Thoracic: Duration of Tube Placement

Duration of chest tube placement and removal will be reported.

Time frame
Up to 30 Days Post Procedure
4

Thoracic: Postoperative Air Leak Duration

Postoperative air leak duration upon submersion test (prior to prophylactic or intervention to the staple line) using a binary determination (air leak, yes/no) will be reported.

Time frame
Up to 30 Days Post Procedure

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: